| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3b4f2ef8f062dcde3a2b7cd81748472
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b01dcd61775e996fac631d4b10c4e87f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f1699224396b5accf82eb97e90cbe4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20 |
| filingDate |
2019-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7e7a1839e17e32b042ddfbe9b03e1d6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b76e0b2eab7a55f15bf93649f62b5b3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f60bf26d4ca824876db3633e038f2ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e5da2f84d3b751492b28a9addefc648
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_43a21dc5276cc2b006b1e0fbbce8d727 |
| publicationDate |
2019-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019158764-A1 |
| titleOfInvention |
Use of interleukin 2 for treating sjögren's syndrome |
| abstract |
The invention relates to the use of interleukin-2 in treating Sjögren's syndrome in a subject, wherein IL-2 is to be administered at a low dose of less than about 3.5 MIU/day. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3927368-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021081193-A1 |
| priorityDate |
2018-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |